Effects of the PPARα Agonist and Widely Used Antihyperlipidemic Drug Gemfibrozil on Hepatic Toxicity and Lipid Metabolism

Gemfibrozil is a widely prescribed hypolipidemic agent in humans and a peroxisome proliferator and liver carcinogen in rats. Three-month feed studies of gemfibrozil were conducted by the National Toxicology Program (NTP) in male Harlan Sprague-Dawley rats, B6C3F1 mice, and Syrian hamsters, primarily...

Descripción completa

Detalles Bibliográficos
Autores principales: Cunningham, Michael L., Collins, Bradley J., Hejtmancik, Milton R., Herbert, Ronald A., Travlos, Gregory S., Vallant, Molly K., Stout, Matthew D.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952818/
https://www.ncbi.nlm.nih.gov/pubmed/20953357
http://dx.doi.org/10.1155/2010/681963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952818/
https://www.ncbi.nlm.nih.gov/pubmed/20953357
http://dx.doi.org/10.1155/2010/681963

Ejemplares similares